Abstract
A 5-year-old boy presented with neutropenia 9 weeks following the administration of rituximab for management of his steroid-dependent nephrotic syndrome. Extensive investigations failed to identify any underlying cause. In keeping with adult reports, rituximab was thought to be the likely cause for this 'late-onset' neutropenia (LOP). He was treated successfully with granulocyte-colony-stimulating factor. Patients treated with rituximab need to be carefully monitored for LOP. Copyright 2013 BMJ Publishing Group. All rights reserved.
Cite
CITATION STYLE
Kshirsagar, A. A., Reid, C. J. D., Alamelu, J., & Sinha, M. D. (2013). An unusual cause of severe persistent neutropenia in a child with nephrotic syndrome. BMJ Case Reports. https://doi.org/10.1136/bcr-2012-007958
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.